Literature DB >> 7131295

Maintenance of schedule-controlled behavior by intravenous injections of nicotine in squirrel monkeys.

R D Spealman, S R Goldberg.   

Abstract

Lever pressing by squirrel monkeys was maintained by i.v. injections of nicotine (3-560 microgram/kg) or cocaine (3-300 microgram/kg) under two intermittent schedules of self-administration. Under a fixed-interval schedule, the first response after a specified interval of time produced an injection. Under a second-order fixed-interval schedule, the completion of every 10-response fixed-ratio unit produced a brief visual stimulus and the first fixed-ratio unit completed after a specified interval produced both the brief stimulus and an injection. As the dose of either drug was increased, the rate of responding first increased and then decreased; maximal response rates maintained by nicotine were approximately equal to those maintained by cocaine in some monkeys, but less than those maintained by cocaine in other monkeys. Patterns of responding maintained by the two drugs were qualitatively similar in all monkeys and were characteristic of performances maintained by other reinforcers under fixed-interval or second-order fixed-interval schedules. Doses of nicotine greater than 30 microgram/kg/injection usually produced vomiting, but often maintained responding well above the rates maintained by saline. When the nicotinic antagonist, mecamylamine (1.0 mg/kg i.m.) was administered before every experimental session, responding maintained by nicotine, but not by cocaine, fell to within saline-control levels; increasing the dose of nicotine to as high as 1700 microgram/kg/injection did not restore responding. Under the intermittent schedules studied here, nicotine served as an effective reinforcer to maintain responding and the reinforcing effects of nicotine were blocked by mecamylamine.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7131295

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  36 in total

1.  Blowing smoke: how cigarette manufacturers argued that nicotine is not addictive.

Authors:  J Sharfstein
Journal:  Tob Control       Date:  1999       Impact factor: 7.552

2.  Galantamine, an acetylcholinesterase inhibitor and positive allosteric modulator of nicotinic acetylcholine receptors, attenuates nicotine taking and seeking in rats.

Authors:  Thomas J Hopkins; Laura E Rupprecht; Matthew R Hayes; Julie A Blendy; Heath D Schmidt
Journal:  Neuropsychopharmacology       Date:  2012-06-06       Impact factor: 7.853

3.  Intravenous nicotine self-administration in rats: effects of mecamylamine, hexamethonium and naloxone.

Authors:  Victor J DeNoble; Paul C Mele
Journal:  Psychopharmacology (Berl)       Date:  2005-08-09       Impact factor: 4.530

4.  The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine.

Authors:  W A Corrigall; K B Franklin; K M Coen; P B Clarke
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

5.  Individual differences in the reinforcing and punishing effects of nicotine in rhesus monkeys.

Authors:  Mikhail N Koffarnus; Gail Winger
Journal:  Psychopharmacology (Berl)       Date:  2015-02-08       Impact factor: 4.530

6.  Nicotine as a typical drug of abuse in experimental animals and humans.

Authors:  Bernard Le Foll; Steven R Goldberg
Journal:  Psychopharmacology (Berl)       Date:  2005-10-05       Impact factor: 4.530

Review 7.  Nicotine self-administration research: the legacy of Steven R. Goldberg and implications for regulation, health policy, and research.

Authors:  Jack E Henningfield; Tracy T Smith; Bethea A Kleykamp; Reginald V Fant; Eric C Donny
Journal:  Psychopharmacology (Berl)       Date:  2016-10-21       Impact factor: 4.530

Review 8.  Hormones, nicotine, and cocaine: clinical studies.

Authors:  Nancy K Mello
Journal:  Horm Behav       Date:  2009-10-14       Impact factor: 3.587

Review 9.  Effects of nicotine in experimental animals and humans: an update on addictive properties.

Authors:  Bernard Le Foll; Steven R Goldberg
Journal:  Handb Exp Pharmacol       Date:  2009

Review 10.  Subtypes of nicotinic acetylcholine receptors in nicotine reward, dependence, and withdrawal: evidence from genetically modified mice.

Authors:  Christie D Fowler; Michael A Arends; Paul J Kenny
Journal:  Behav Pharmacol       Date:  2008-09       Impact factor: 2.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.